With global scientific output surging by nearly 60% in a decade, R&D teams are now expected to navigate millions of new peer-reviewed articles every single year (NSF, National Science Board). The knowledge that doesn’t make it into journals is many times larger, but both are often invisible to R&D teams. Much of what a lab learns never reaches a journal at all, including negative results, side observations, and half-finished ideas. Somewhere in that is likely the answer your team is looking for. This could be a novel material, a validated method, or a mechanism you haven’t even considered yet. This observation came up while talking to NotedSource’s Head of Research and Client Success Ramy Ayoub. “During my PhD at the University of Toronto, I spent a full summer working alongside two summer students to test the efficacy of a novel therapy for radiation-induced cognitive deficits in pediatric brain tumour survivors. The results after months of work ended up null, which meant that I had to pivot searching for therapies that would work and that would yield findings compelling enough for top-tier journals.” 

While most R&D teams focus on applied research, a common blind spot is basic research, as it is done to understand how something works, not to build a product. The researchers who hold that knowledge want it found too, as applied impact increasingly means funding, recognition and getting their science out into the world.

 

Why most published science stays invisible to industry

Academic publishing is organized around disciplinary peer review, not commercial application. Papers are categorized by mechanism, method or field and not by the industry problem they might solve. The findings relevant to a food company’s shelf-life challenge may sit in a pharmaceutical sciences journal under scientific terminology the product team may not think to search for. The materials insight relevant to consumer packaging may appear in aerospace literature. Or the solution to a cosmetics company’s problem might live in a marine biology journal. In medicine, where the lag is best studied, research takes an average of 17 years to move from evidence to practice (Morris, Wooding & Grant, 2011). Part of that lag may be the time it takes for the right person to find the science. 

Finding the paper is only half the problem. Evaluating it is its own challenge. Not all published findings carry equal weight. Study design, sample size, methodology and reproducibility all determine whether a result will hold up outside the lab. Critically reviewing a publication is a trained skill and without it teams risk building on findings that won’t translate or the opposite, dismissing ones that will. 

 

Why knowledge is missing from publications

Academic publishing has a well-documented bias. Negative results, null findings and methodological dead ends are published at lower rates. Fewer than half of studies first presented as conference abstracts ever reach full publication (Scherer et al., 2018). This is not because they lack value. The publishing system rewards what worked, not everything that was learned. This knowledge is not retrievable by combing through academic databases, as it’s accessible only through a direct partnership with the researchers who hold it. That engagement works best as an exchange where researchers are compensated for their expertise, while companies get practical insights no database can provide. For an R&D team, this data is often the most commercially relevant. It includes the approach a lab spent time ruling out that may be the same approach an internal team is about to attempt or what the research article couldn’t capture.

 

How NotedSource addresses this

NotedSource can assist with each of these problems: finding the science, evaluating it, and engaging the researchers behind the knowledge that was never published. The shift toward external innovation is already well underway. Nearly 42% of businesses are looking to deepen their external networks (Deloitte). In my role as Research Lead, I work with a team of PhDs who work as translators between R&D organizations and academia. We read basic science with an applied eye and critically evaluate what we find. Because we have worked on the academic side, we speak the language the literature is written in and know how research groups operate. For knowledge that never made it into print, we connect teams directly with the researchers who hold it, drawing on a network of over 50,000 vetted experts. Every expert in our network has opted in, is compensated for their time and works under clear agreements, allowing both sides to collaborate with confidence and get science out of the lab and into the world.

Your next breakthrough may be waiting in a university lab. The question is whether your R&D team has a reliable way to find it.